Market Overview

Morning Market Losers

Related THLD
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Threshold Pharmaceuticals Receives FDA Fast Track Designation For TH-302 For The Treatment Of Previously Untreated Patients With Metastatic Or Locally Advanced Unresectable Soft Tissue Sarcoma
Threshold Pharmaceuticals Just Turned Up the Heat (AEMD, THLD, AMDA) (Small Cap Network)
Related TRGT
Stocks Hitting 52-Week Lows
Morning Market Losers

Threshold Pharmaceuticals (NASDAQ: THLD) fell 28.10% to $6.27 at 9:55 am. Threshold Pharmaceuticals announced data from Phase 2b clinical trial of TH-302 in combination with Gemcitabine.

Targacept (NASDAQ: TRGT) shares dipped 11.34% to $4.30. Targacept reported top-line results from a Phase 2 trial of TC-5619 in adults with inattentive-predominant attention deficit/hyperactivity disorder.

Tandy Brands Accessories (NASDAQ: TBAC) shares lost 10.74% to $1.33. Tandy Brands Accessories' trailing-twelve-month ROE is -12.63%.

MGC Diagnostics (NASDAQ: MGCD) dropped 10.51% to $5.28. MGC Diagnostics' trailing-twelve-month operating margin is -1.93%.

Posted-In: News Movers & Shakers Intraday Update Markets


Related Articles (TBAC + MGCD)

Around the Web, We're Loving...

Get Benzinga's Newsletters